Replies to post #1980 on Repro Med Systems Inc (REPR)

[truthfinder2012]

Yes, and the CEO was recently asked in a radio interview what he saw going forward, and he basically said he did not like to give guidance, but he thought you could look at what they have done the past few years with their growth rate. So he is expecting 30% growth still.

Lots of new opportunities worldwide too. Like Hizentra should be sold in Japan soon, etc.,

This is currently the most undervalued growth stock (at a P/E of like 8 or so now) in all of the microcaps. (I do stock screens quite often and I can't find a better micro growth stock with a solid balance sheet like this).

[seeksup]

Below from the quarter ended 11/30/12. Nice increases in sales, but a one-time bonus, the hiring of key personnel to expand sales, and increased costs for trade shows and marketing really hurt the net profit, income, and EPS. I keep waiting for REPR to sustain an increase in both Sales and EPS...

Q ending 8/2012

Net Sales 1,951,608
Net Op Profit 541,993
Net Income 350,644
Net inc/share 0.01

Q ending 11/2012

Net Sales 2,070,409
Net Op Profit 87,391
Net Income 55,524
Net inc/share 0.00